Skip to content
WeighLab
Menu
Ranked #517 · Grade C

Zealthy review

Zealthy is a broad telehealth platform whose weight-loss arm sells GLP-1s three ways: an insurance-routed path for branded Ozempic/Wegovy/Zepbound/Mounjaro (advertised 'as low as $25/month' but dependent on coverage being secured).

Visit Zealthy Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$297/mo (bundle, plus a separate fee, compounded)
Tirzepatide
$449/mo (bundle, plus a separate fee, compounded)
Coverage
34 states
Brand-name
Yes

Semaglutide · modeled / year

$3,564

Tirzepatide · modeled / year

$5,388

Pricing verified August 2026

The Index scorecard

Zealthy scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month20/100
Price Transparency20/100
Nationwide Access66/100
Formulation Options79/100
Clinical Oversight49/100
Contract Flexibility33/100

Where the value is

  • Offers a genuine insurance-coordination path for branded Wegovy/Zepbound/Ozempic/Mounjaro, unlike most other companies in this batch which are cash-pay compounded-only
  • The all-in 'Doctor + GLP-1' bundle is transparent about being all-in and includes a stated full-refund policy 'no questions asked' if a patient is found clinically ineligible
  • Broader platform than a single-purpose GLP-1 shop — primary care, mental health, and other services are available under the same account

The tradeoffs

  • The site's most prominent headline price ($151/month semaglutide, $216/month tirzepatide) requires a 3-month prepay AND excludes a separate membership fee whose dollar amount is not disclosed anywhere in the weight-loss FAQ — a naive reader would not know a second charge exists
  • The true all-in monthly cost is $297 (semaglutide) or $449 (tirzepatide) via the bundled plan, roughly double the advertised a la carte headline figure
  • The advertised '$25/month' insurance price is not guaranteed — it depends on plan coverage and Zealthy's coordination team successfully securing it
  • No named medical director, no named compounding pharmacy, and no state-coverage list found anywhere I could access
  • FDA issued FitRX, LLC dba Zealthy a warning letter in September 2025; the letter is public in FDA's warning-letter database

The bottom line

Best for: Shoppers with insurance who want Zealthy's coordination team to chase brand-name coverage, rather than those seeking the lowest simple cash price. Zealthy is a broad telehealth platform whose weight-loss arm sells GLP-1s three ways: an insurance-routed path for branded Ozempic/Wegovy/Zepbound/Mounjaro (advertised 'as low as $25/month' but dependent on coverage being secured).

Ranked #517 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Zealthy.

The 21 programs nearest this one

Pricing, states and verification reflect Zealthy's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Zealthy's site. Not medical advice; see our disclosure.

← Back to the value leaderboard